Research Center Profile:
Hattiesburg Clinic Neurological Research Center
The Neurological Research Center (NRC) is a service of Hattiesburg Clinic. Our goal is to partner with both academia and industry to provide the residents of South Mississippi with access to leading-edge clinical trials.
The NRC has conducted phase II, III, and IV clinical trials with focus on neurological disease. The NRC is able to utilize a Central Institutional Review Board. The Center's special interests include Alzheimer disease, Parkinson's disease, epilepsy, stroke, migraine, as well as other disorders that affect the nervous system. The center has been involved in clinical research since 2005.
NRC physicians provide evaluation and treatment in both the inpatient and outpatient setting. The center has On-site laboratory (certified by the State Board) -20 C freezer, dry ice, centrifuge; On-site full service pharmacy; On-site imaging department with 1.5 Tesla Magnetic Resonance Imaging and 3 Tesla Magnetic Resonance Imaging, PET Imaging, 64 slice CT scanner, Densitometry, Nuclear Medicine, and Ultrasound; Neurodiagnostics including Electroencephalography (EEG), 24-hour EEG/Video Monitoring, Electromyography (EMG) and nerve conduction, Electronystagmography (ENG), and Tilt table; Neuropsychological testing and dedicated, secure research space.
Located within Hattiesburg Clinic, a physician-owned group practice with more than 200 physicians, NRC is staffed by board certified Neurologists who oversee all aspects of clinical trials. Support Personnel include a study coordinator and clinical study manager who provide services necessary for the efficient achievement of research objectives.
We are located across the street from Forrest General Hospital, a 512 bed, level II regional trauma center.
Ronald L. Schwartz, MD, CPI
Director and Principle Investigator
Dr. Schwartz graduated from Columbia University, in NYC. He received his medical degree from Albany Medical College, Albany, NY. He completed a neurology residency at Albert Einstein College of Medicine, Bronx, NY and a fellowship in behavioral neurology at the University of Florida. Dr. Schwartz is board-certified in neurology with sub-specialty certification in behavioral neurology/neuropsychiatry. He is also a certified physician investigator.
Patients will be chosen from our clinic database, advertisements, referrals, etc.
The NRC is able to utilize a Central Institutional Review Board.
Active studies, not enrolling:
- Genentech ABE4955g for Mild to Moderate Alzheimer's disease
- Study of the effect on cognitive performance, safety and tolerability of SAR110894D at doses of 0.5 mg, 2 mg and 5 mg/day for 24 weeks in patients with mild to moderate Alzheimer's Disease on stable donepezil therapy
If you are interested in contacting this center to discuss placing a clinical
trial there, please complete and send the email form below. A representative from
the research center will then follow up with you.